|
Veröffentlichungen
1. Randomised, double-blind, placebo-controlled study on the efficacy and tolerance of trospium chloride in patients
with motor urge incontinence. Ulshöfer-B, Bihr-A-M, Bödeker-R-H, Schwantes-U, Jahn-H-P. Clinical Drug Investigation, 2001, Vol/Iss/Pg. 21/8(563-5692. Bioavailability of trospium
chloride after intravesical instillation in patients with neurogenic lower urinary tract dysfunction: A pilot study. Walter-P, Grosse-J, Bihr-A-M, Kramer-G, Schulz-H-U, Schwantes-U, Stöhrer-M.
Neurourology and Urodynamics, 1999, Vol/Iss/Pg. 18/5 (447-453) 3. Serumspiegel von Trospiumchlorid nach einmaliger intravesikaler Instillation. Kramer-G, Walter-P, Grosse-J, Bihr-A-M
, Schulz-H-U, Schwantes-U, Stöhrer-M. Der Urologe A, 1999, Vol/Iss/Pg. 38/Suppl. 1 (S50) 4. Effect of trospium chloride on duodenal motility during upper
gastrointestinal endoscopy: A randomised, double-blind, placebo- controlled trial. Rohde-H, Bihr-A-M, Schwantes-U, Eisebitt-R, Meurer-J, Fischer-M, Topfmeier-P.
Clinical Drug Investigation, 1997, Vol/Iss/Pg. 13/2 (85-89) 5. Lack of influence of glycine on the single dose pharmacokinetics of acetylsalicylic acid in man. Schürer-M, Bias-Imhoff-U, Schulz-H-U, Schwantes-U,
Riechers-A-M International journal of clinical pharmacology and therapeutics, 1996, Vol/Iss/Pg. 34/7 (282-287) |